Popular Pre-Market Trades in US Stocks
NLS Pharmaceutics is up 10.12% in pre-market trading. Based on recent key news:
<ol>
<li>
On October 29, NLS Pharmaceutics announced that all significant conditions for its merger with Kadimastem have been completed, and the merged company will be listed on NASDAQ under the name NewCelX Ltd. with the stock code NCEL. This news drove the stock price up.
</li>
<li>
On October 29, NLS Pharmaceutics announced a 1-for-10 reverse stock split and will be renamed NewcelX Ltd., expected to take effect on October 31. This move aims to enhance the market liquidity and attractiveness of the stock, further driving up the stock price.
</li>
<li>
On October 29, NASDAQ approved NLS Pharmaceutics' listing application, marking the company's progress in the pharmaceutical field and enhancing its market position. This milestone event boosted investor confidence and pushed the stock price higher. Mergers and acquisitions in the biopharmaceutical industry are frequent, leading to increased market volatility.
</li>
</ol>
Cleveland Cliffs is down 9.58% in pre-market trading. Based on recent key news:
<ol>
<li>
On October 30, Cleveland Cliffs announced plans to issue 75 million shares to repay borrowings under its asset-backed credit facility, with the remaining net proceeds used for general corporate purposes. This news caused the stock price to drop 8.1% in after-hours trading, closing at $12.95.
</li>
<li>
On October 20, Cleveland Cliffs' stock rose about 21% to $16.18 due to third-quarter losses being lower than expected and improvements in its automotive business, along with the announcement of a rare earth exploration plan.
</li>
<li>
On October 27, analysts' consensus rating for Cleveland Cliffs is hold, with an average target price of $12.51. The steel industry has been quite volatile recently, and policy changes should be monitored
</li>
</ol>

NLSP

NLS Pharmaceutics pre-market up 10.12%; Cleveland Cliffs pre-market down 9.58%;

Pre-market hot trades in the US stock market: NLS Pharmaceutics up 10.12% in pre-market; Cleveland Cliffs down 9.58% in pre-market